|Titre :||The extent of and factors associated with self-reported overdose and self-reported receipt of naloxone among people who inject drugs (PWID) in England, Wales and Northern Ireland (2017)|
|Auteurs :||C. O'HALLORAN ; K. CULLEN ; J. NJOROGE ; L. JESSOP ; J. SMITH ; V. HOPE ; F. NCUBE|
|Type de document :||Article : Périodique|
|Dans :||International Journal of Drug Policy (Vol.46, August 2017)|
|Article en page(s) :||34-40|
|Note générale :||
Response: Survey representativeness, quantifying uncertainty, and the importance of well-posed questions about the administration of take-home naloxone. Bird S.M., International Journal of Drug Policy, 2018; 51: p. 18-19.
Corrigendum: International Journal of Drug Policy, 2018; 57: p. 133-135.
|Discipline :||EPI (Epidémiologie / Epidemiology)|
Thésaurus TOXIBASESURDOSE ; NALOXONE ; USAGER ; HEROINE ; CRACK ; AMPHETAMINES ; INJECTION
Thésaurus GéographiqueROYAUME-UNI ; ANGLETERRE ; PAYS DE GALLES ; IRLANDE DU NORD
Background: Overdose is a major cause of death among PWID, and for opioid overdoses naloxone administration can reduce harm. However, globally there is limited national level data on the extent of non-fatal overdose and naloxone uptake. The first national level data on the extent of self-reported overdose and self-reported receipt of naloxone among UK PWID, providing a baseline to monitor the impact of the recent policy change regarding naloxone availability, is presented.
Methods: Data on self-reported overdose and receipt of naloxone during the preceding year for 2013-2014 from a national survey of PWID was analysed. Participants who reported injecting during the preceding year were included.
Results: Participants (3850) were predominantly male (75%); mean age was 36 years. The most commonly injected drugs were: heroin (91%), crack (45%) and amphetamine (29%). 15% (591) reported overdosing during the preceding year. There were no differences in the proportion reporting overdose by age or gender, but overdose was more common among those who: injected multiple drugs; recently ceased addiction treatment; injected with used needles/syringes; ever had transactional sex; had used a sexual health clinic or emergency department and lived in Wales or Northern Ireland. Among those reporting an overdose during the preceding year, a third reported two to four overdoses and 7.5% five or more overdoses; half reported receiving naloxone. Those reporting naloxone receipt in the preceding year were more likely to: live in Wales or Northern Ireland; ever received used needles/syringes; ever been imprisoned; and less likely to have injected two drug types.
Conclusion: These data provide a baseline for monitoring the impact of the 2015 UK policy change to improve take-home naloxone access. Interventions tackling overdose should promote naloxone awareness and access, and target those who; are poly-drug injectors, have ceased treatment, share needles/syringes and whose drug use links to sexual activity.
|Domaine :||Drogues illicites / Illicit drugs|
|Affiliation :||HIV & STI Department, Public Health England, London, UK|